VitaNova Life Sciences Corp — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that VitaNova Life Sciences Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Apr 30, 2023 | $38.0K | May 15, 2023 |
| FY2023 | Apr 30, 2022 | $120.0K | May 15, 2023 |
| FY2022 | Apr 30, 2021 | $0 | May 16, 2022 |
| FY2021 | Apr 30, 2020 | $0 | Jul 1, 2021 |
| FY2020 | Apr 30, 2019 | $0 | Aug 5, 2020 |
| FY2019 | Apr 30, 2018 | $0 | Jul 30, 2019 |
| FY2018 | Jan 25, 2017 | $0 | Jul 17, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $2.66M | Jul 24, 2025 |
| FY2025 | Apr 30, 2024 | $570.7K | Jul 24, 2025 |
| FY2024 | Apr 30, 2023 | $38.0K | Jul 29, 2024 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $1.58M | Jul 24, 2025 |
| FY2025 | Apr 30, 2024 | $377.7K | Jul 24, 2025 |
| FY2024 | Apr 30, 2023 | $38.0K | Jul 29, 2024 |
| FY2019 | Apr 30, 2019 | $0 | Jul 30, 2019 |
| FY2019 | Apr 30, 2018 | $0 | Jul 30, 2019 |
| FY2018 | Jan 25, 2017 | $0 | Jul 17, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $850.7K | Jul 24, 2025 |
| FY2025 | Apr 30, 2024 | $140.9K | Jul 24, 2025 |
| FY2024 | Apr 30, 2023 | ($24.2K) | Jul 29, 2024 |
| FY2023 | Apr 30, 2022 | $139.7K | May 15, 2023 |
| FY2022 | Apr 30, 2021 | ($52.1K) | May 16, 2022 |
| FY2021 | Apr 30, 2020 | ($72.3K) | Jul 1, 2021 |
| FY2020 | Apr 30, 2019 | ($106.2K) | Aug 5, 2020 |
| FY2019 | Apr 30, 2018 | ($1.6K) | Jul 30, 2019 |
| FY2018 | Apr 30, 2017 | ($7.2K) | Jul 17, 2018 |
| FY2018 | Jan 25, 2017 | ($7.2K) | Jul 17, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $1.21M | Jul 24, 2025 |
| FY2025 | Apr 30, 2024 | $205.6K | Jul 24, 2025 |
| FY2024 | Apr 30, 2023 | ($24.2K) | Jul 29, 2024 |
| FY2023 | Apr 30, 2022 | ($13.4K) | May 15, 2023 |
| FY2022 | Apr 30, 2021 | ($52.1K) | May 16, 2022 |
| FY2021 | Apr 30, 2020 | ($72.3K) | Jul 1, 2021 |
| FY2020 | Apr 30, 2019 | ($71.8K) | Aug 5, 2020 |
| FY2019 | Apr 30, 2018 | ($48.6K) | Jul 30, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $192.8K | Jul 24, 2025 |
| FY2025 | Apr 30, 2024 | ($375.9K) | Jul 24, 2025 |
| FY2024 | Apr 30, 2023 | ($18.4K) | Jul 29, 2024 |
| FY2023 | Apr 30, 2022 | $4.1K | May 15, 2023 |
| FY2022 | Apr 30, 2021 | ($42.3K) | May 16, 2022 |
| FY2021 | Apr 30, 2020 | ($53.6K) | Jul 1, 2021 |
| FY2020 | Apr 30, 2019 | ($49.1K) | Aug 5, 2020 |
| FY2019 | Apr 30, 2018 | ($9.3K) | Jul 30, 2019 |
| FY2018 | Jan 25, 2017 | ($6.5K) | Jul 17, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $2.26M | Jul 24, 2025 |
| FY2025 | Apr 30, 2024 | $1.19M | Jul 24, 2025 |
| FY2024 | Apr 30, 2023 | $8.7K | Jul 29, 2024 |
| FY2023 | Apr 30, 2022 | $23.1K | May 15, 2023 |
| FY2022 | Apr 30, 2021 | $0 | May 16, 2022 |
| FY2021 | Apr 30, 2020 | $0 | Jul 1, 2021 |
| FY2020 | Apr 30, 2019 | $0 | Aug 5, 2020 |
| FY2019 | Apr 30, 2018 | $47.8K | Jul 30, 2019 |
| FY2018 | Apr 30, 2017 | $2.4K | Jul 17, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $347.6K | Jul 24, 2025 |
| FY2025 | Apr 30, 2024 | $136.9K | Jul 24, 2025 |
| FY2024 | Apr 30, 2023 | $67.9K | Jul 29, 2024 |
| FY2023 | Apr 30, 2022 | $58.1K | May 15, 2023 |
| FY2022 | Apr 30, 2021 | $174.7K | May 16, 2022 |
| FY2021 | Apr 30, 2020 | $122.6K | Jul 1, 2021 |
| FY2020 | Apr 30, 2019 | $50.2K | Aug 5, 2020 |
| FY2019 | Apr 30, 2018 | $5.6K | Jul 30, 2019 |
| FY2018 | Apr 30, 2017 | $7.9K | Jul 17, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $1.91M | Jul 24, 2025 |
| FY2025 | Apr 30, 2024 | $1.06M | Jul 24, 2025 |
| FY2025 | Apr 30, 2023 | ($59.2K) | Jul 24, 2025 |
| FY2024 | Apr 30, 2022 | ($35.0K) | Jul 29, 2024 |
| FY2023 | Apr 30, 2021 | ($174.7K) | May 15, 2023 |
| FY2022 | Apr 30, 2020 | ($122.6K) | May 16, 2022 |
| FY2021 | Apr 30, 2019 | ($50.2K) | Jul 1, 2021 |
| FY2020 | Apr 30, 2018 | $42.2K | Aug 5, 2020 |
| FY2019 | Apr 30, 2017 | ($3.7K) | Jul 30, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $867.7K | Jul 24, 2025 |
| FY2025 | Apr 30, 2024 | $17.0K | Jul 24, 2025 |
| FY2024 | Apr 30, 2023 | ($123.9K) | Jul 29, 2024 |
| FY2023 | Apr 30, 2022 | ($99.7K) | May 15, 2023 |
| FY2022 | Apr 30, 2021 | ($239.4K) | May 16, 2022 |
| FY2021 | Apr 30, 2020 | ($187.3K) | Jul 1, 2021 |
| FY2020 | Apr 30, 2019 | ($114.9K) | Aug 5, 2020 |
| FY2019 | Apr 30, 2018 | ($8.8K) | Jul 30, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Apr 30, 2023 | $8.7K | May 15, 2023 |
| FY2023 | Apr 30, 2022 | $23.1K | May 15, 2023 |
| FY2022 | Apr 30, 2021 | $0 | May 16, 2022 |
| FY2021 | Apr 30, 2020 | $0 | Jul 1, 2021 |
| FY2021 | Apr 30, 2019 | $0 | Jul 1, 2021 |
| FY2020 | Apr 30, 2018 | $4.4K | Aug 5, 2020 |
| FY2019 | Apr 30, 2017 | $205 | Jul 30, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | 0 | Jul 24, 2025 |
| FY2025 | Apr 30, 2024 | 0 | Jul 24, 2025 |
| FY2024 | Apr 30, 2023 | 0 | Jul 29, 2024 |
| FY2023 | Apr 30, 2022 | 0 | May 15, 2023 |
| FY2022 | Apr 30, 2021 | 0 | May 16, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | 0 | Jul 24, 2025 |
| FY2025 | Apr 30, 2024 | 0 | Jul 24, 2025 |
| FY2024 | Apr 30, 2023 | 0 | Jul 29, 2024 |
| FY2023 | Apr 30, 2022 | 0 | May 15, 2023 |
| FY2022 | Apr 30, 2021 | 0 | May 16, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | 25.01M | Jul 24, 2025 |
| FY2025 | Apr 30, 2024 | 25.01M | Jul 24, 2025 |
| FY2024 | Apr 30, 2023 | 5.87M | Jul 29, 2024 |
| FY2023 | Apr 30, 2022 | 5.87M | May 15, 2023 |
| FY2022 | Apr 30, 2021 | 5.87M | May 16, 2022 |
| FY2021 | Apr 30, 2020 | 5.87M | Jul 1, 2021 |
| FY2020 | Apr 30, 2019 | 5.87M | Aug 5, 2020 |
| FY2019 | Apr 30, 2018 | 5.87M | Jul 30, 2019 |
| FY2018 | Apr 30, 2017 | 3.50M | Jul 17, 2018 |